Skip to main content
NewslettersWatchlist

Valeo Pharmainc(VPH-T)
TSX

Today's Change
Real-Time Last Update
Day Low0.0450
Day High0.0450
Open:0.0450
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
AI-generated - The Globe and Mail
Valeo Pharma: Top 10 Undervalued Drug Manufacturers Industry Stocks (VPH)
AI-generated - The Globe and Mail
Valeo Pharma: Top 25 Undervalued Toronto Stock Exchange Stocks (VPH)
Newswire.ca
VALEO PHARMA INITIATES RESTRUCTURING PROCEEDINGS UNDER THE CCAA TO IMPLEMENT A REVIEW OF ITS STRATEGIC ALTERNATIVES
AI-generated - The Globe and Mail
Valeo Pharma: Top 10 Undervalued Drug Manufacturers Industry Stocks (VPH)
AI-generated - The Globe and Mail
Valeo Pharma: Top 25 Undervalued Toronto Stock Exchange Stocks (VPH)
Newswire.ca
VALEO PHARMA REPORTS THIRD QUARTER 2024 REVENUES
Newswire.ca
VALEO PHARMA TO HOST THIRD QUARTER 2024 RESULTS CONFERENCE CALL / WEBCAST
Baystreet
Stocks in play: Valeo Pharma Inc.
Newswire.ca
VALEO PHARMA AMENDS CREDIT FACILITY WITH SAGARD HEALTHCARE ROYALTY PARTNERS, LP
AI-generated - The Globe and Mail
Valeo Pharma: Top 10 Undervalued Drug Manufacturers Industry Stocks (VPH)
Baystreet
Stocks in play: Valeo Pharma Inc.
Newswire.ca
VALEO PHARMA ANNOUNCES VOLUNTARY DELISTING FROM OTCQB VENTURE MARKET
AI-generated - The Globe and Mail
Valeo Pharma: Top 10 Undervalued Nano Cap Stocks on TSX (VPH)
AI-generated - The Globe and Mail
Valeo Pharma: Top 25 Undervalued Toronto Stock Exchange Stocks (VPH)
AI-generated - The Globe and Mail
Valeo Pharma: Top 10 Undervalued Nano Cap Stocks on TSX (VPH)
Newswire.ca
VALEO PHARMA ANNOUNCES LEADERSHIP CHANGES
AI-generated - The Globe and Mail
Valeo Pharma: Top 10 Undervalued Drug Manufacturers Industry Stocks (VPH)
AI-generated - The Globe and Mail
Valeo Pharma: Top 10 Undervalued Drug Manufacturers Industry Stocks (VPH)
AI-generated - The Globe and Mail
Valeo Pharma: Top 10 Undervalued Healthcare Sector Stocks on TSX (VPH)
Newswire.ca
VALEO PHARMA ANNOUNCES SENIOR EXECUTIVE APPOINTMENT AND BOARD OF DIRECTORS CHANGE
Newswire.ca
VALEO PHARMA REPORTS RECORD SECOND QUARTER 2024 REVENUES
Baystreet
Stocks in play: Valeo Phama Inc.

Profile

Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and hospital specialty products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.